Preclinical scientific studies advise that retatrutide may influence weight problems-affiliated most cancers development. In a research led by Marathe et al., retatrutide-induced weight-loss lessened tumor engraftment, delayed tumor onset, and considerably attenuated tumor development in pancreatic and lung cancer types, with larger tumor suppressi